Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Targeted Genetics commences phase I trial of tgDCC-E1A for ovarian cancer

Dec. 17, 1999

Schwarz to develop Cephalon's prostate cancer drugs in Europe

Dec. 17, 1999

AEterna and the NCI file IND for Neovastat in North America

Dec. 17, 1999

Paclimer Microspheres from Guilford progresses to human studies

Dec. 16, 1999

Novel naturally occurring DNA polymerase beta inhibitor discovered at U. of Virginia

Dec. 16, 1999

Banyu tests improved successor to NB-506

Dec. 16, 1999

COX-2 inhibitor suggested to be active in squamous cell carcinoma

Dec. 16, 1999

MGI Pharma commences phase I weekly dosing study with irofulven

Dec. 16, 1999

Camptosar designated for priority review for new indication

Dec. 16, 1999

FDA advisory committee recommends approval of Celebrex as adjunctive therapy for FAP

Dec. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...